x
Breaking News
More () »

Healthy Living: Innovative Kidney Cancer Treatment Now Offered at Baptist Health

Jelmyto provides an effective, kidney-sparing option for patients with low-grade upper tract urothelial cancer.

Kyle Basham, MD, a urologist at Baptist Health-Fort Smith, is now offering a new treatment for patients with a rare and difficult-to-treat form of kidney cancer. Jelmyto was approved by the U.S. Food and Drug Administration (FDA) last spring. Dr. Basham is the first in Arkansas to offer the Jelmyto treatment.

Sponsored by: Baptist Health